Early versus delayed laparoscopic cholecystectomy for uncomplicated biliary colic

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Gurusamy, Kurinchi Selvan ^a   Koti, Rahul ^a   Fusai, Giuseppe ^a   Davidson, Brian R ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CHOLECYSTITIS; ALL CAUSE MORTALITY; ARTICLE; BILE DUCT INJURY; BILIARY COLIC; CHOLANGITIS; CLINICAL ASSESSMENT; DELAYED LAPAROSCOPIC CHOLECYSTECTOMY; EARLY LAPAROSCOPIC CHOLECYSTECTOMY; EMPYEMA; GALLBLADDER PERFORATION; GALLSTONE; HOSPITAL ADMISSION; HOSPITAL MORTALITY; HUMAN; LAPAROSCOPIC CHOLECYSTECTOMY; LENGTH OF STAY; NONHUMAN; OBSTRUCTIVE JAUNDICE; OPEN SURGERY; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREATITIS; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETURN TO WORK; RISK BENEFIT ANALYSIS; SURGICAL APPROACH; SURGICAL MORTALITY; SYSTEMATIC REVIEW; ADULT; BILIARY TRACT DISEASES; CHOLECYSTECTOMY; COLIC; COMPLICATION; FEMALE; MALE; TIME; TIME TO TREATMENT;

ADULT; BILIARY TRACT DISEASES; CHOLECYSTECTOMY, LAPAROSCOPIC; COLIC; FEMALE; HUMANS; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; TIME-TO-TREATMENT;

EID: 84891672178     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD007196.pub3     Document Type: Article

References (54)

1. Macafee DA, Humes DJ, Bouliotis G, Beckingham IJ, Whynes DK, Lobo DN. Prospective randomized trial using cost-utility analysis of early versus delayed laparoscopic cholecystectomy for acute gallbladder disease. British Journal of Surgery 2009;96(9):1031-40.
2. Salman B, Yuksel O, Irkorucu O, Akyurek N, Tezcaner T, Dogan I, et al.Urgent laparoscopic cholecystectomy is the best management for biliary colic. A prospective randomized study of 75 cases. Digestive Surgery 2005;22(1-2):95-9.
3. Schmidt M, Sondenaa K, Vetrhus M, Berhane T, Eide GE. A randomized controlled study of uncomplicated gallstone disease with a 14-year follow-up showed that operation was the preferred treatment. Digestive Surgery 2011;28(4):270-6.
4. Vetrhus M, Søreide O, Solhaug JH, Nesvik I, Søndenaa K. Symptomatic, non-complicated gallbladder stone disease. Operation or observation? A randomized clinical study. Scandinavian Journal of Gastroenterology 2002;37(7):834-9.
5. Attili AF, De Santis A, Capri R, Repice AM, Maselli S. The natural history of gallstones: The GREPCO experience. The GREPCO group. Hepatology 1995;21(3):655-60.
6. Ballal M, David G, Willmott S, Corless DJ, Deakin M, Slavin JP. Conversion after laparoscopic cholecystectomy in England. Surgical Endoscopy 2009;23(10):2338-44.
7. Bates T, Harrison M, Lowe D, Lawson C, Padley N. Longitudinal study of gall stone prevalence at necropsy. Gut 1992;33(1):103-7.
8. Berger MY, van der Velden JJ, Lijmer JG, de Kort H, Prins A, Bohnen AM. Abdominal symptoms: do they predict gallstones? A systematic review. Scandinavian Journal of Gastroenterology 2000;35(1):70-6.
9. Bingener J, Schwesinger WH, Chopra S, Richards ML, Sirinek KR. Does the correlation of acute cholecystitis on ultrasound and at surgery reflect a mirror image?. American Journal of Surgery 2004;188(6):703-7.
10. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. Journal of Clinical Epidemiology 2008;61:763-9.
11. Brok J, Thorlund K, Wetterslev J, Gluud C. Apparently conclusive meta-analyses may be inconclusive - Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. International Journal of Epidemiology 2009;38(1):287-98.
12. Copenhagen Trial Unit. TSA - Trial Sequential Analysis. http://ctu.dk/tsa/ 2011 (accessed 31 May 2013).
13. DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341-50.
14. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177-88.
15. Dolan JP, Diggs BS, Sheppard BC, Hunter JG. The national mortality burden and significant factors associated with open and laparoscopic cholecystectomy: 1997-2006. Journal of Gastrointestinal Surgery 2009;13(12):2292-301.
16. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ (Clinical Research Ed.) 1997;315(7109):629-34.
17. Glasgow RE, Cho M, Hutter MM, Mulvihill SJ. The spectrum and cost of complicated gallstone disease in California. Archives of Surgery 2000;135(9):1021-5; discussion 1025-7.
18. Gluud C, Nikolova D, Klingenberg SL, Alexakis N, Als-Nielsen B, Colli A, et al.Cochrane Hepato-Biliary Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2013, Issue 5. Art. No.: LIVER.
19. GREPCO. Prevalence of gallstone disease in an Italian adult female population. Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). American Journal of Epidemiology 1984;119(5):796-805.
20. GREPCO. The epidemiology of gallstone disease in Rome, Italy. Part i. Prevalence data in men. The Rome Group for the Epidemiology and Prevention of Cholelithiasis (GREPCO). Hepatology 1988;8(4):904-6.
21. Gurusamy KS, Davidson C, Samraj K, Gluud C, Davidson BR. Early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Cochrane Database of Systematic Reviews 2013, Issue 6. [DOI: 10.1002/14651858.CD005440.pub2]
22. Halldestam I, Enell EL, Kullman E, Borch K. Development of symptoms and complications in individuals with asymptomatic gallstones. British Journal of Surgery 2004;91(6):734-8.
23. HESonline. Hospital Episode Statistics. Main procedures and interventions: 3 character. http://www.hesonline.nhs.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=205 2011 (accessed on 31 May 2013).
24. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
25. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Colloboration, 2011. Available from www.cochrane-handbook.org.
26. International Conference on Harmonisation Expert Working Group. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline. Guideline for good clinical practice CFR & ICH Guidelines. Vol. 1, PA 19063-2043, USA: Barnett International/PAREXEL, 1997.
27. Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses. Annals of Internal Medicine 2001;135(11):982-9.
28. Lawrentschuk N, Hewitt PM, Pritchard MG. Elective laparoscopic cholecystectomy: implications of prolonged waiting times for surgery. Australian and New Zealand Journal of Medicine 2003;73(11):890-3.
29. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.MR000033.pub2]
30. Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta-analysis. Statistics in Medicine 2001;20(4):641-54.
31. Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al.Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?. Lancet 1998;352(9128):609-13.
32. Moher D, Schulz KF, Altman DG (for the CONSORT Group). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357(9263):1191-4.
33. Newell DJ. Intention-to-treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837-41.
34. NIH. NIH consensus statement on gallstones and laparoscopic cholecystectomy. http://consensus.nih.gov/1992/1992GallstonesLaparoscopy090html.htm 1992 (accessed 31 May 2013).
35. Peng WK, Sheikh Z, Nixon SJ, Paterson-Brown S. Role of laparoscopic cholecystectomy in the early management of acute gallbladder disease. British Journal of Surgery 2005;92:586-91.
36. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
37. Royle P, Milne R. Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. International Journal of Technology Assessment in Health Care 2003;19(4):591-603.
38. Rutledge D, Jones D, Rege R. Consequences of delay in surgical treatment of biliary disease. American Journal of Surgery 2000;180(6):466-9.
39. Savović J, Jones HE, Altman DG, Harris RJ, Juni P, Pildal J, et al.Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Annals of Internal Medicine 2012;157(6):429-38.
40. Savović J, Jones HE, Altman DG, Harris RJ, Jüni P, Pildal J, et al.Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials. Health Technology Assessment 2012;16(35):1-82.
41. Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408-12.
42. Shea JA, Berlin JA, Escarce JJ, Clarke JR, Kinosian BP, Cabana MD, et al.Revised estimates of diagnostic test sensitivity and specificity in suspected biliary tract disease. Archives of Internal Medicine 1994;154(22):2573-81.
43. Sobolev B, Mercer D, Brown P, FitzGerald M, Jalink D, Shaw R. Risk of emergency admission while awaiting elective cholecystectomy. Canadian Medical Association Journal 2003;169(7):662-5.
44. Somasekar K, Shankar PJ, Foster ME, Lewis MH. Costs of waiting for gall bladder surgery. Postgraduate Medical Journal 2002;78(925):668-9.
45. Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, et al.SPIRIT 2013 Statement: defining standard protocol items for clinical trials. Annals of Internal Medicine 2013;158:200-7.
46. Strasberg SM, Clavien PA. Overview of therapeutic modalities for the treatment of gallstone diseases. American Journal of Surgery 1993;165(4):420-6.
47. Thorlund K, Devereaux PJ, Wetterslev J, Guyatt G, Ioannidis JP, Thabane L, et al.Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses. International Journal of Epidemiology 2009;38(1):276-86.
48. Thorlund K, Anema A, Mills E. Interpreting meta-analysis according to the adequacy of sample size. An example using isoniazid chemoprophylaxis for tuberculosis in purified protein derivative negative HIV-infected individuals. Clinical Epidemiology 2010;2:57-66.
49. Thorlund K, Engstrøm J, Wetterslev J, Brok J, Imberger G, Gluud C. User manual for Trial Sequential Analysis (TSA). http://ctu.dk/tsa/files/tsa_manual.pdf 2011 (accessed 31 May 2013).
50. Trowbridge RL, Rutkowski NK, Shojania KG. Does this patient have acute cholecystitis?. JAMA 2003;289(1):80-6.
51. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. Journal of Clinical Epidemiology 2008;61(1):64-75.
52. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Medical Research Methodology 2009;9:86.
53. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al.Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ (Clinical Research Ed.) 2008;336:601-5.
54. Gurusamy KS, Samraj K, Fusai G, Davidson BR. Early versus delayed laparoscopic cholecystectomy for biliary colic. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD007196.pub2]